The global separation system for commercial biotechnology market is expected to reach USD 39.47 billion by 2025, according to a new report by Grand View Research, Inc. Intensive research in the field of biotechnology to develop advanced products is expected to boost growth in the coming years. Moreover, contributions of leading industrial entities in this sector for accelerating commercial production is anticipated to drive the market.
Government bodies are providing funds to small & medium enterprises for the development of novel technologies. This is expected to enhance the efficiency of large-scale upstream bioprocessing systems used for separation & purification of biomolecules. Such instruments are extensively used for production of food & cosmetics, agriculture, plastics, and chemicals.
Moreover, the popularity of technologically advanced single-use bioprocessing systems in various industries, such as agro-processing, chemical & plastics is contributing toward the growth of the upstream processing sector. Rising cases of chronic & severe metabolic & genetic disorders are ultimately increasing the demand of potential therapeutics. Rising demand for biopharmaceuticals is likely to result in lucrative growth.
Furthermore, changing healthcare reforms and public -private collaborations among industrial players, government, and research institutions are expected to improve the technological aspects of separation methods. Thus, in turn, is anticipated to significantly render the growth of commercial separation market over the forecast period.
To request a sample copy or view summary of this report, click the link below:
Further Key Findings from the Report Suggest:
Conventional separation techniques are estimated to account for the largest revenue share owing to technological advancements in the segment
However, modern methods are anticipated to grow at the fastest pace in the coming years due to rise in adoption of these technologies
Technological advancements in product capabilities are anticipated to boost the market
Pharmaceutical industry accounted for the largest revenue share owing to higher usage of systems for commercialization of therapeutics
Rising prevalence of various chronic disorders is indirectly boosting growth
North America dominated the market with adequate administration support, extensive research, and well-established industrial framework
Asia Pacific region is expected to exhibit fastest growth over the forecast period owing to progressive industrialization and favorable government support
Major players include Shimadzu Corporation; PerkinElmer, Inc.; Agilent Technologies; GE Healthcare; Thermo Fisher Scientific; Bio-Rad Laboratories, Inc.; bioMérieux SA; Merck & Co., Inc.; WATERS; Hitachi Koki Co., Ltd.; QIAGEN; Sartorius;BD; Danaher; and Miltenyi Biotec
Companies are entering into collaborations with academic institutions, private, and public entities to accelerate product development and launch novel systems
Grand View Research has segmented the separation systems for commercial biotechnology market on the basis of methods, application, and region:
Method Outlook (Revenue, USD Million; 2014 - 2025)
Application Outlook (Revenue, USD Million; 2014 - 2025)
Human Blood Plasma Fractionation
Mammalian Cell Cultures
Food & Cosmetics
Regional Outlook (Revenue, USD Million; 2014 - 2025)
Middle East and Africa (MEA)
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.